The adverse outcome pathway for skin sensitisation: Moving closer to replacing animal testing

Terry W Schultz1, Gergana Dimitrova2, Sabcho Dimitrov2

  • 1The University of Tennessee, College of Veterinary Medicine, Knoxville, TN, USA.

Insights

The Organisation for Economic Co-operation and Development (OECD) developed an Adverse Outcome Pathway (AOP) for skin sensitization, earning the 2015 Lush Black Box Prize. This AOP integrates data and influences regulatory policy and animal testing alternatives.

Area of Science:

  • Toxicology and Chemical Safety
  • Regulatory Science
  • In silico toxicology

Background:

  • The Organisation for Economic Co-operation and Development (OECD) received the 2015 Lush Black Box Prize for its work on skin sensitization.
  • The core of this work was the development of the 'Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins'.

Purpose of the Study:

  • To present the OECD's award-winning work on the Adverse Outcome Pathway (AOP) for skin sensitization.
  • To summarize recent advancements in integrated approaches to testing and assessment (IATA) based on this AOP.
  • To discuss the AOP's influence on regulatory policy and the Three Rs (Replacement, Reduction, Refinement) in animal testing.

Main Methods:

  • Development of the Adverse Outcome Pathway (AOP) for skin sensitization.
  • Integration of mechanistic data for skin sensitization assessment.
  • Application of the AOP within integrated approaches to testing and assessment (IATA).
  • Overview of the next-generation skin sensitization AOP module in the OECD QSAR Toolbox.

Main Results:

  • The established AOP provides a mechanistic framework for understanding and assessing skin sensitization.
  • Recent developments enable enhanced integrated approaches to testing and assessment (IATA) for skin sensitization.
  • The AOP has demonstrably impacted regulatory policy and the implementation of the Three Rs.

Conclusions:

  • The OECD's Adverse Outcome Pathway for Skin Sensitisation is a significant advancement in toxicological science.
  • This AOP facilitates data integration, supports regulatory decision-making, and promotes animal welfare.
  • Ongoing development, including the OECD QSAR Toolbox module, promises further refinement of skin sensitization assessment.

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
85
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.4K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
114
Allergic Reactions02:06

Allergic Reactions

Overview
33.2K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.0K